Home » Stocks » BDX

Becton, Dickinson and Company (BDX)

Stock Price: $246.45 USD 5.57 (2.31%)
Updated Mar 5, 2021 4:00 PM EST - Market closed
Market Cap 71.10B
Revenue (ttm) 18.21B
Net Income (ttm) 1.51B
Shares Out 290.03M
EPS (ttm) 5.26
PE Ratio 46.89
Forward PE 19.27
Dividend $3.20
Dividend Yield 1.30%
Trading Day March 5
Last Price $246.45
Previous Close $240.88
Change ($) 5.57
Change (%) 2.31%
Day's Open 241.84
Day's Range 240.95 - 247.61
Day's Volume 1,105,590
52-Week Range 196.42 - 283.99

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 49 minutes ago

Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock?

Other stocks mentioned: BDXA
24/7 Wall Street - 2 days ago

When the market is expensive and overbought like the current one is, it is very important to stay with companies that not only have solid earnings potential but also have upcoming catalysts th...

Other stocks mentioned: DXCM, MDT
PRNewsWire - 2 days ago

FRANKLIN LAKES, N.J., March 4, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired GSL Solutions, ...

The Motley Fool - 1 week ago

The new president has a lot of work to do, and many companies are likely to benefit from some of his priorities.

Other stocks mentioned: AXON, CSX
GuruFocus - 1 week ago

Leading medical device manufacturer Becton, Dickinson & Co. (NYSE:BDX), or BD, recently reported earnings results that showed the company greatly benefited from Covid-19-related sales. BD prov...

Other stocks mentioned: BDXA
Zacks Investment Research - 1 week ago

BD (BDX) plans to develop a lateral flow antigen test and pair it with the Scanwell Health mobile app via the latest partnership.

Other stocks mentioned: BDXA
The Motley Fool - 2 weeks ago

It's possible that some stocks could fly higher with the policy change being considered by the Biden administration.

Other stocks mentioned: ABT, FLGT, QDEL
InvestorPlace - 2 weeks ago

Health care companies may not be at the front of mind when thinking of stocks with dividends, but these three are winners. The post 3 High-Quality Health Care Companies With Recession-Proof Di...

Other stocks mentioned: BMY, MDT
Zacks Investment Research - 2 weeks ago

The dental equipment market seems ready to grow as it continues to recover from the COVID-19 pandemic slump, making it prudent to look at names like Henry Schein (HSIC) and McKesson (MCK)

Other stocks mentioned: ALGN, HSIC, MCK
Zacks Investment Research - 2 weeks ago

BD's (BDX) new test has the capability to detect SARS-CoV-2 and Influenza A+B in a single test.

Other stocks mentioned: BDXA
PRNewsWire - 2 weeks ago

The solution leverages a modular platform technology that allows rapid customization, optimizing time and cost for pharma companies SANTA CLARA, Calif., Feb. 16, 2021 /PRNewswire/ -- Based on ...

Other stocks mentioned: BDXA
PRNewsWire - 3 weeks ago

FRANKLIN LAKES, N.J., Feb. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the fol...

Benzinga - 3 weeks ago

The FDA has granted Emergency Use Authorization (EUA) to Becton Dickinson and Co's (NYSE: BDX) new molecular test for both SARS-CoV-2 and Influenza A+B. The new test has also received a CE mar...

Other stocks mentioned: BDXA
PRNewsWire - 3 weeks ago

FRANKLIN LAKES, N.J., Feb. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Adm...

CNBC Television - 1 month ago

Covid-19 testing drives Becton Dickinson Q1 revenue growth

Medical devices company Becton Dickinson beat the top and bottom line in its first-quarter results. Covid-19 testing helped drive its revenue growth to $867 million.

Other stocks mentioned: BDXA
Zacks Investment Research - 1 month ago

Becton Dickinson (BDX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Other stocks mentioned: BDXA
The Motley Fool - 1 month ago

Selling shovels doesn't get stale if the gold rush never ends.

Other stocks mentioned: PKI, TMO
Zacks Investment Research - 1 month ago

Each of Becton Dickinson's (BDX) core units witnesses strong revenue growth in the fiscal first quarter.

Other stocks mentioned: BDXA
Zacks Investment Research - 1 month ago

Becton Dickinson (BDX) delivered earnings and revenue surprises of 44.90% and 0.13%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Other stocks mentioned: BDXA
PRNewsWire - 1 month ago

FRANKLIN LAKES, N.J., Feb. 4, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $5.315 bill...

PRNewsWire - 1 month ago

FRANKLIN LAKES, N.J., Feb. 2, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that new clinical data have foun...

Zacks Investment Research - 1 month ago

Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Other stocks mentioned: BDXA
Zacks Investment Research - 1 month ago

BD's (BDX) first-quarter fiscal 2021 results are likely to reflect strong year-over-year growth in revenues from assays in its Life Sciences segment.

GlobeNewsWire - 1 month ago

SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NYSE: BDX shares. Investors, who purchased NYSE: BDX...

Other stocks mentioned: BDXA
PRNewsWire - 1 month ago

FRANKLIN LAKES, N.J., Jan. 26, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, BD CEO and president...

PRNewsWire - 1 month ago

FRANKLIN LAKES, N.J., Jan. 25, 2021 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, payabl...

Zacks Investment Research - 1 month ago

As of late, it has definitely been a great time to be an investor in Becton, Dickinson and Company (BDX).

Other stocks mentioned: BDXA
Seeking Alpha - 1 month ago

Healthcare aristocrats benefit from significant medical device contributions. By and large these healthcare aristocrats share favorable quant metrics on Seeking Alpha, albeit with significant ...

Other stocks mentioned: ABT, CAH, JNJ, MDT
Zacks Investment Research - 1 month ago

The Department of Health and Human Services (HHS) promises over $22 billion of funding.

Other stocks mentioned: ABT, HOLX, QDEL
Seeking Alpha - 1 month ago

Welcome to Alpha Trader. We have a special double bill today in honor of wildcard weekend coming up on the show. Eddy Elfenbein of Crossing Wall Street giving us his top five new stocks for 20...

Other stocks mentioned: ABT, CWS, EGBN, GL, HEI, HRL, MLR, RPM, TMO, ZTS
Zacks Investment Research - 1 month ago

BD (BDX) projects its fiscal Q1 revenues to surge from the year-ago figure, primarily on the back of high demand for its COVID-19 diagnostic tests

Zacks Investment Research - 1 month ago

The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.

Other stocks mentioned: ABT, DGX, HOLX, LH, QDEL, QGEN
CNBC Television - 1 month ago

Final Trades: Zynga, Becton Dickinson & more

The "Halftime Report" investment committee give their top picks to watch for the second half.

Other stocks mentioned: BDXA, ZNGA, FANUY
Zacks Investment Research - 1 month ago

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Other stocks mentioned: BDXA
Seeking Alpha - 1 month ago

This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher speaking with LPL Financial's Ryan Detrick and Eddy Elfenbein, editor of the Crossing Wall Street blog and portfol...

Other stocks mentioned: ABT, CWS, EGBN, GL, HEI, HRL, MLR, RPM, TMO, ZTS
Market Watch - 1 month ago

Shares of Becton Dickinson & Co. rallied 2.3% in premarket trading Tuesday, after the medical technology company provided an upbeat outlook for its first quarter. For the quarter ended Dec. 31...

Other stocks mentioned: BDXA
PRNewsWire - 1 month ago

FRANKLIN LAKES, N.J., Jan. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported, preliminary unaudited financial...

Zacks Investment Research - 1 month ago

Here we discuss four dividend-paying value stocks, MCK, CAH, BDX and HRC, which though trading cheap now, have solid chances of a rebound in the second half of 2021.

Other stocks mentioned: CAH, HRC, MCK
InvestorPlace - 2 months ago

The Covid-19 vaccine rally isn't just limited to biotech firms. Here are the top coronavirus stocks that are making mass vaccination possible.

Other stocks mentioned: AVTR, JNJ, MRNA, PFE, TMO, WST
GuruFocus - 2 months ago

Other stocks mentioned: BDXA
Seeking Alpha - 2 months ago

In previous articles I analyzed Abbott and Medtronic. BD is their somewhat smaller peer, and a company I own.

PRNewsWire - 2 months ago

FRANKLIN LAKES, N.J., Dec. 22, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 39t...

InvestorPlace - 2 months ago

Large-cap stocks have seen wildly varying performance in 2020. And in 2021, these four names should be among the group's best.

Other stocks mentioned: ERIC, NFLX, SJM
GuruFocus - 2 months ago

The health care sector is considered a defensive sector as people will seek out treatment for illness and aliments regardless of the status of the economy. Many companies in this sector litera...

Other stocks mentioned: BDXA
GuruFocus - 2 months ago

When it comes to Covid-19, Becton, Dickinson and Co. (NYSE:BDX) hasn't gained the attention of vaccine developers like Pfizer Inc. (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ), nor those compan...

Other stocks mentioned: BDXA
PRNewsWire - 2 months ago

FRANKLIN LAKES, N.J., Dec. 9, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced publication of the results from ...

Zacks Investment Research - 3 months ago

Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock?

Other stocks mentioned: BDXA
Zacks Investment Research - 3 months ago

Let's see if Becton, Dickinson (BDX) stock is a good choice for value-oriented investors right now from multiple angles.

Other stocks mentioned: BDXA
Seeking Alpha - 3 months ago

All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. An average increase of 4.06% and a median increase of 3.64%.

Other stocks mentioned: ADP, AEE, FAF, HPQ, MDU, SJI, SR, UMBF, VFC
Zacks Investment Research - 3 months ago

BD (BDX) is set to improve its pre-fillable syringe-manufacturing ability with its expansion and upgrade plans.

About BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; in... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Apr 23, 1962
CEO
Thomas Polen
Employees
70,000
Stock Exchange
NYSE
Ticker Symbol
BDX
Full Company Profile

Financial Performance

In 2020, BDX's revenue was $17.12 billion, a decrease of -1.00% compared to the previous year's $17.29 billion. Earnings were $874.00 million, a decrease of -29.17%.

Financial Statements

Analyst Forecasts

According to 18 analysts, the average rating for BDX stock is "Buy." The 12-month stock price forecast is 281.57, which is an increase of 14.25% from the latest price.

Price Target
$281.57
(14.25% upside)
Analyst Consensus: Buy